Tianjin Pengling Group (300375.SZ) plans to invest in acquiring 8.49105% equity of Wuhan Liyan.
Penglai Lingfei Holdings (300375.SZ) announced that the company plans to invest a total of 30 million yuan through equity transfer and capital increase, acquiring 8.49105% equity of Wuhan Liyan, with a corresponding pre-investment valuation of 520 million yuan.
Tianjin Pengling Group (300375.SZ) announced that the company plans to invest a total of 30 million yuan through equity transfer and capital increase, acquiring 8.49105% equity of Wuhan Liyan, corresponding to a pre-investment valuation of 520 million yuan.
Based on the company's three-year strategic plan and market development direction analysis, in order to achieve the strategic goal of development in the intelligent machine parts industry by focusing on the main business and strengthening profit margins, the company needs to enable higher technological manufacturing attributes on its existing business map. The target company belongs to the sensor industry with technological attributes, producing inductive position sensors mainly used in steering systems, braking systems, etc., and its products and underlying technologies can extend to the field of intelligent machine parts. In this investment, the company will implement it in the form of equity participation, actively exploring high-quality enterprises upstream and downstream of the industrial chain on a basis of controllable risk, helping optimize and upgrade the company's product structure and enhance its core competitiveness.
Related Articles

Nanhua Futures (603093.SH) published the information collection after the hearing on the issuance of H shares.

Shanghai Fosun Pharmaceutical(02196): Liu Yi elected as executive director

JIANGSU HORIZON (02625) completed the placement of approximately 21.39 million new shares, raising a net amount of approximately 58.55 million Hong Kong dollars.
Nanhua Futures (603093.SH) published the information collection after the hearing on the issuance of H shares.

Shanghai Fosun Pharmaceutical(02196): Liu Yi elected as executive director

JIANGSU HORIZON (02625) completed the placement of approximately 21.39 million new shares, raising a net amount of approximately 58.55 million Hong Kong dollars.






